CompanyGraph
Zhejiang Gongdong Medical Technology Co., Ltd.
605369 · SSE · China
gongdong.comFinancials as of FY2025
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleLevered free cash flow is $24.53M, above the global median of $16.24M
- FinancialsAltman Z-Score 7.2: safe zone
- Interpretations2 currently firing — 2
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.74%
Annual Rate
CNY 0.30Paid semi-annual
Payout Ratio
109.9%High
Payback Period
39.6 yr
Last Ex-Dividend
Jun 18, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.89BCNY578.89M · vs all stocks (USD)
Trailing P/E
66.38xvs Medical Instruments & Supplies peers
Revenue (TTM)
1.16BCNY172.48M · vs all stocks (USD)
Profit Margin
4.84%vs Medical Instruments & Supplies peers
Beta
0.5810xvs all stocks
52-Week Change
-15.55%vs all stocks
Forward Annual Dividend Yield
1.74%vs all stocks
Market Capitalization
3.89BCNY578.89M · vs all stocks (USD)
Enterprise Value
3.28BCNY488.37M · vs all stocks (USD)
Trailing P/E
66.38xvs Medical Instruments & Supplies peers
Forward P/E
17.78xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
3.27xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
2.14xvs Medical Instruments & Supplies peers
Enterprise to Revenue
2.83xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
17.18xvs Medical Instruments & Supplies peers
Gross Margin
32.46%vs Medical Instruments & Supplies peers
Profit Margin
4.84%vs Medical Instruments & Supplies peers
Operating Margin
15.59%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
3.10%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
3.21%vs Medical Instruments & Supplies peers
Revenue (TTM)
1.16BCNY172.48M · vs all stocks (USD)
Revenue per Share (TTM)
5.27CNYUpdated Aug 21, 2026Quarterly Revenue Growth
9.10%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
313.27MCNY46.59M · vs all stocks (USD)
EBITDA (TTM)
120.28MCNY17.89M · vs all stocks (USD)
Net Income (TTM)
56.09MCNY8.34M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
16.70%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
284.75MCNY42.34M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
164.98MCNY24.53M · vs all stocks (USD)
Forward Annual Dividend Rate
0.3000CNYUpdated Aug 21, 2026Forward Annual Dividend Yield
1.74%vs all stocks
Trailing Annual Dividend Rate
0.4357CNYUpdated Aug 21, 2026Trailing Annual Dividend Yield
2.52%vs all stocks
Payout Ratio
109.89%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
17.74MCNYFY2025 · Dec 31, 2025Revenue
1.14BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
819.18MCNYFY2025 · Dec 31, 2025Gross Profit
316.52MCNYFY2025 · Dec 31, 2025Operating Income
113.19MCNY16.83M · vs all stocks (USD)
Pre-tax Income
62.83MCNYFY2025 · Dec 31, 2025Income Tax Expense
11.46MCNYFY2025 · Dec 31, 2025Net Income
51.38MCNYFY2025 · Dec 31, 2025EBIT
68.49MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
207.26MCNYFY2025 · Dec 31, 2025Research & Development
45.60MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
61.82MCNYFY2025 · Dec 31, 2025Other Operating Expenses
12.58MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
17.84MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
5.65MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.2300CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.2300CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
223.94MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
223.94MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
51.38MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
127.62KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
62.38MCNYFY2025 · Dec 31, 2025Free Cash Flow
-49.04MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
527.85MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
51.38MCNYFY2025 · Dec 31, 2025Other Non-cash Items
17.15MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
5.52MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-11.67MCNYFY2025 · Dec 31, 2025Capital Expenditures
-111.42MCNYFY2025 · Dec 31, 2025Net Acquisitions
-18.98MCNYFY2025 · Dec 31, 2025Purchase of Investments
-90.66MCNYFY2025 · Dec 31, 2025Sale of Investments
140.47MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-80.59MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
245.00MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-120.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-65.68MCNYFY2025 · Dec 31, 2025Other Financing Charges
5.92MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
65.24MCNYFY2025 · Dec 31, 2025Shares Outstanding
220.49MSharesUpdated Aug 21, 2026Float Shares
63.87MSharesUpdated Aug 21, 2026% Held by Insiders
69.33%vs all stocks
% Held by Institutions
4.30%vs all stocks
Total Cash (MRQ)
702.30MCNY104.44M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.29CNYUpdated Aug 21, 2026Total Debt (MRQ)
240.50MCNY35.76M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1386xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
2.73xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
8.05CNYUpdated Aug 21, 2026Total Assets
2.12BCNY315.08M · vs all stocks (USD)
Total Current Assets
1.08BCNYFY2025 · Dec 31, 2025Total Liabilities
412.53MCNYFY2025 · Dec 31, 2025Total Non-current Assets
1.04BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
32.91MCNYFY2025 · Dec 31, 2025Total Current Liabilities
379.62MCNYFY2025 · Dec 31, 2025Cash
527.85MCNYFY2025 · Dec 31, 2025Cash Equivalents
4.80MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
532.65MCNYFY2025 · Dec 31, 2025Other Short-term Investments
92.79MCNYFY2025 · Dec 31, 2025Accounts Receivable
278.28MCNYFY2025 · Dec 31, 2025Inventory
138.13MCNYFY2025 · Dec 31, 2025Accounts Payable
114.13MCNYFY2025 · Dec 31, 2025Short-term Debt
139.75MCNYFY2025 · Dec 31, 2025Other Current Liabilities
1.69MCNYFY2025 · Dec 31, 2025Long-term Debt
24.62MCNYFY2025 · Dec 31, 2025Common Stock (Book)
220.49MCNYFY2025 · Dec 31, 2025Retained Earnings
758.92MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.71BCNY253.73M · vs all stocks (USD)
Treasury Stock
23.05MCNYFY2025 · Dec 31, 202552-Week Low
14.75CNYUpdated Aug 21, 202652-Week High
22.68CNYUpdated Aug 21, 202652-Week Change
-15.55%vs all stocks
Beta
0.5810xvs all stocks
50-Day MA
16.87CNYUpdated Aug 21, 2026200-Day MA
18.34CNYUpdated Aug 21, 2026Avg 10-Day Volume
1.56MSharesUpdated Aug 21, 2026Avg 30-Day Volume
1.77MSharesUpdated Aug 21, 2026Diluted EPS (TTM)
0.2600CNYUpdated Aug 21, 20262 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Retained Earnings Heavy With Elevated Payout
Profits kept in the business fund much of what it owns, and it now pays out most of what it earns.
Reads
How is this stock valued?
High Retained Earnings With Profitability And Equity
Profits kept in the business fund much of what it owns, after five straight profitable years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 7.2: safe zoneNotable
Altman Z-Score: 7.20
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Levered free cash flow is $24.53M, above the global median of $16.24MNotable
Levered free cash flow (USD): 24,534,161.524Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Zhangjiagang Guangda Special Material Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowSenseMaking
Shandong Haihua Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Marshalls plc
Tier 1ProductionThroughput-Bound ConversionFlowRule
Yunnan Yunwei Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Shandong Lubei Chemical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
China Sunsine Chemical Holdings Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Tongling Zhongfa Trinity Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Beijing Tieke Shougang Railway Technology Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Southern Cable Group Berhad
Tier 1ProductionThroughput-Bound ConversionFlowRule
Eastern Communications Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Skp Resources Berhad
2 interpretationsRetained Earnings Heavy With Elevated PayoutHigh Retained Earnings With Profitability And Equity
Shanxi Lu'an Environmental Energy Development Co., Ltd.
2 interpretationsRetained Earnings Heavy With Elevated PayoutHigh Retained Earnings With Profitability And Equity
FP Holdings, Inc.
2 interpretationsRetained Earnings Heavy With Elevated PayoutHigh Retained Earnings With Profitability And Equity